Teriflunomide Delays MS Symptoms in RIS Teriflunomide Delays MS Symptoms in RIS

For patients with radiologically isolated syndrome (RIS) predictive of multiple sclerosis (MS), teriflunomide reduced the risk of a demyelinating event over a 2-year period in a phase 3 trial.MDedge News
Source: Medscape Radiology Headlines - Category: Radiology Tags: Neurology & Neurosurgery News Source Type: news